| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Palsy | 26 | 2013 | 82 | 3.870 |
Why?
|
| Orthopedics | 13 | 2022 | 96 | 2.360 |
Why?
|
| Radius Fractures | 10 | 2021 | 74 | 1.890 |
Why?
|
| Hand | 25 | 2019 | 80 | 1.820 |
Why?
|
| Fingers | 24 | 2021 | 78 | 1.780 |
Why?
|
| Neuromuscular Agents | 10 | 2012 | 37 | 1.630 |
Why?
|
| Muscle Spasticity | 12 | 2013 | 31 | 1.420 |
Why?
|
| Fracture Fixation, Internal | 8 | 2021 | 131 | 1.370 |
Why?
|
| Upper Extremity | 7 | 2021 | 69 | 1.350 |
Why?
|
| Range of Motion, Articular | 16 | 2019 | 209 | 1.290 |
Why?
|
| Wrist Injuries | 9 | 2021 | 48 | 1.280 |
Why?
|
| Humans | 153 | 2023 | 34562 | 1.280 |
Why?
|
| Ischemia | 11 | 2021 | 119 | 1.260 |
Why?
|
| Muscle, Skeletal | 11 | 2011 | 575 | 1.220 |
Why?
|
| Orthopedic Procedures | 6 | 2022 | 101 | 1.170 |
Why?
|
| Complex Regional Pain Syndromes | 5 | 2016 | 24 | 1.070 |
Why?
|
| Arteries | 10 | 2021 | 83 | 1.020 |
Why?
|
| Arm | 10 | 2010 | 44 | 1.010 |
Why?
|
| External Fixators | 4 | 2019 | 21 | 0.900 |
Why?
|
| Cold Temperature | 16 | 2011 | 61 | 0.900 |
Why?
|
| Tendon Transfer | 3 | 2018 | 18 | 0.890 |
Why?
|
| Diagnosis | 2 | 2016 | 4 | 0.860 |
Why?
|
| Male | 99 | 2021 | 20740 | 0.820 |
Why?
|
| Arterial Occlusive Diseases | 5 | 2014 | 38 | 0.810 |
Why?
|
| Conflict of Interest | 7 | 2016 | 36 | 0.800 |
Why?
|
| Sympathectomy | 8 | 2021 | 24 | 0.780 |
Why?
|
| Multicenter Studies as Topic | 3 | 2021 | 120 | 0.770 |
Why?
|
| Physician's Role | 2 | 2016 | 41 | 0.770 |
Why?
|
| Peripheral Nerves | 6 | 2023 | 65 | 0.750 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2021 | 565 | 0.740 |
Why?
|
| Child | 35 | 2013 | 2614 | 0.700 |
Why?
|
| Finger Joint | 4 | 2018 | 14 | 0.690 |
Why?
|
| Treatment Outcome | 22 | 2021 | 3623 | 0.670 |
Why?
|
| Reflex Sympathetic Dystrophy | 7 | 2004 | 15 | 0.670 |
Why?
|
| Self Concept | 2 | 2016 | 47 | 0.650 |
Why?
|
| Casts, Surgical | 4 | 2021 | 28 | 0.630 |
Why?
|
| Quality of Life | 11 | 2013 | 1032 | 0.620 |
Why?
|
| Patient Satisfaction | 3 | 2021 | 245 | 0.620 |
Why?
|
| Veins | 5 | 2008 | 35 | 0.620 |
Why?
|
| Adolescent | 40 | 2015 | 3805 | 0.590 |
Why?
|
| Raynaud Disease | 5 | 2011 | 13 | 0.590 |
Why?
|
| Hand Injuries | 4 | 2010 | 26 | 0.580 |
Why?
|
| Female | 70 | 2021 | 21532 | 0.570 |
Why?
|
| Dupuytren Contracture | 1 | 2018 | 2 | 0.550 |
Why?
|
| Hand Deformities, Acquired | 1 | 2018 | 3 | 0.550 |
Why?
|
| Electromyography | 5 | 2011 | 68 | 0.550 |
Why?
|
| Injections, Intramuscular | 14 | 2013 | 57 | 0.550 |
Why?
|
| Internship and Residency | 1 | 2022 | 330 | 0.540 |
Why?
|
| Replantation | 7 | 2001 | 15 | 0.530 |
Why?
|
| Body Temperature Regulation | 15 | 2003 | 26 | 0.530 |
Why?
|
| Botulinum Toxins | 6 | 2008 | 43 | 0.510 |
Why?
|
| Physician-Patient Relations | 6 | 2013 | 188 | 0.500 |
Why?
|
| Musculoskeletal Diseases | 2 | 2008 | 44 | 0.490 |
Why?
|
| Child, Preschool | 21 | 2013 | 1355 | 0.490 |
Why?
|
| Middle Aged | 44 | 2021 | 12726 | 0.480 |
Why?
|
| Tibial Fractures | 3 | 2011 | 35 | 0.480 |
Why?
|
| Nerve Regeneration | 6 | 2023 | 51 | 0.470 |
Why?
|
| Aftercare | 1 | 2016 | 35 | 0.470 |
Why?
|
| Neuromuscular Blockade | 3 | 2001 | 12 | 0.460 |
Why?
|
| Patient Care Planning | 1 | 2016 | 58 | 0.450 |
Why?
|
| Neuromuscular Junction | 5 | 2015 | 76 | 0.450 |
Why?
|
| Peripheral Vascular Diseases | 3 | 2008 | 35 | 0.440 |
Why?
|
| Bone Plates | 4 | 2021 | 74 | 0.430 |
Why?
|
| Laser-Doppler Flowmetry | 13 | 2011 | 35 | 0.430 |
Why?
|
| Muscle Tonus | 2 | 2011 | 7 | 0.430 |
Why?
|
| Follow-Up Studies | 18 | 2021 | 2367 | 0.420 |
Why?
|
| Pain, Postoperative | 3 | 2015 | 205 | 0.420 |
Why?
|
| Adult | 47 | 2016 | 10030 | 0.420 |
Why?
|
| Equinus Deformity | 3 | 2003 | 5 | 0.410 |
Why?
|
| Patient Care | 6 | 2008 | 29 | 0.400 |
Why?
|
| Osteotomy | 2 | 2010 | 57 | 0.400 |
Why?
|
| Postoperative Complications | 8 | 2016 | 850 | 0.400 |
Why?
|
| Contracture | 5 | 2008 | 18 | 0.400 |
Why?
|
| Colles' Fracture | 1 | 2013 | 1 | 0.400 |
Why?
|
| Thrombosis | 5 | 2008 | 88 | 0.390 |
Why?
|
| Rats, Sprague-Dawley | 14 | 2012 | 923 | 0.390 |
Why?
|
| Animals | 35 | 2013 | 8579 | 0.390 |
Why?
|
| Fracture Fixation | 2 | 2011 | 48 | 0.390 |
Why?
|
| Social Responsibility | 1 | 2013 | 14 | 0.380 |
Why?
|
| Amputation, Traumatic | 6 | 2001 | 14 | 0.380 |
Why?
|
| Prospective Studies | 12 | 2023 | 2463 | 0.380 |
Why?
|
| Clinical Protocols | 1 | 2013 | 87 | 0.380 |
Why?
|
| Disabled Children | 2 | 2003 | 21 | 0.370 |
Why?
|
| Ear | 8 | 2000 | 18 | 0.370 |
Why?
|
| United States | 11 | 2022 | 4278 | 0.370 |
Why?
|
| Receptors, Nicotinic | 3 | 2007 | 62 | 0.360 |
Why?
|
| Clubfoot | 2 | 2008 | 5 | 0.360 |
Why?
|
| Radial Artery | 3 | 2008 | 16 | 0.360 |
Why?
|
| Joint Deformities, Acquired | 2 | 2010 | 13 | 0.360 |
Why?
|
| Rats | 15 | 2012 | 1946 | 0.350 |
Why?
|
| Birth Injuries | 2 | 2010 | 29 | 0.350 |
Why?
|
| Brachial Plexus Neuropathies | 2 | 2010 | 39 | 0.340 |
Why?
|
| Vascular Surgical Procedures | 4 | 2008 | 90 | 0.340 |
Why?
|
| Neurologic Examination | 2 | 2008 | 31 | 0.340 |
Why?
|
| Muscle Strength | 3 | 2011 | 157 | 0.330 |
Why?
|
| Military Medicine | 1 | 2011 | 26 | 0.330 |
Why?
|
| GAP-43 Protein | 2 | 2007 | 8 | 0.330 |
Why?
|
| Pain Measurement | 8 | 2021 | 385 | 0.330 |
Why?
|
| Models, Statistical | 1 | 2021 | 193 | 0.330 |
Why?
|
| Keratins | 4 | 2013 | 42 | 0.330 |
Why?
|
| Ultrasonography | 10 | 2016 | 417 | 0.320 |
Why?
|
| Knee Joint | 5 | 2008 | 151 | 0.320 |
Why?
|
| Femoral Fractures | 1 | 2011 | 48 | 0.320 |
Why?
|
| Ulnar Artery | 2 | 2008 | 4 | 0.320 |
Why?
|
| Neurosurgical Procedures | 2 | 2015 | 101 | 0.310 |
Why?
|
| Online Systems | 2 | 2000 | 12 | 0.310 |
Why?
|
| Specialties, Surgical | 1 | 2010 | 27 | 0.310 |
Why?
|
| Fractures, Bone | 3 | 2006 | 157 | 0.310 |
Why?
|
| Wrist | 4 | 1998 | 51 | 0.310 |
Why?
|
| Pain | 4 | 2005 | 330 | 0.300 |
Why?
|
| Muscle Contraction | 6 | 2013 | 183 | 0.300 |
Why?
|
| Shoulder Joint | 2 | 2010 | 141 | 0.300 |
Why?
|
| Leg | 3 | 2000 | 71 | 0.300 |
Why?
|
| Finger Injuries | 2 | 2006 | 10 | 0.300 |
Why?
|
| Microcirculation | 18 | 2012 | 72 | 0.290 |
Why?
|
| Foot Ulcer | 1 | 2008 | 5 | 0.290 |
Why?
|
| Time Factors | 13 | 2021 | 2353 | 0.290 |
Why?
|
| Foot Deformities, Acquired | 5 | 1994 | 9 | 0.290 |
Why?
|
| Psychomotor Disorders | 1 | 2008 | 5 | 0.290 |
Why?
|
| Median Nerve | 2 | 2013 | 53 | 0.290 |
Why?
|
| Wounds and Injuries | 2 | 2016 | 248 | 0.290 |
Why?
|
| Myogenic Regulatory Factors | 2 | 2007 | 9 | 0.280 |
Why?
|
| Bone Transplantation | 3 | 1997 | 53 | 0.280 |
Why?
|
| Tissue Scaffolds | 4 | 2013 | 435 | 0.280 |
Why?
|
| Hemophilia A | 1 | 2008 | 26 | 0.280 |
Why?
|
| Neuromuscular Junction Diseases | 1 | 2007 | 5 | 0.270 |
Why?
|
| Carpal Tunnel Syndrome | 3 | 2015 | 65 | 0.270 |
Why?
|
| Thrombocythemia, Essential | 1 | 2007 | 3 | 0.270 |
Why?
|
| Aged | 20 | 2021 | 11022 | 0.270 |
Why?
|
| Regional Blood Flow | 15 | 2012 | 95 | 0.260 |
Why?
|
| Achilles Tendon | 1 | 2007 | 26 | 0.260 |
Why?
|
| Recovery of Function | 6 | 2021 | 251 | 0.260 |
Why?
|
| Retrospective Studies | 12 | 2021 | 3825 | 0.250 |
Why?
|
| Exercise Therapy | 1 | 2019 | 283 | 0.250 |
Why?
|
| Surgical Flaps | 6 | 1997 | 78 | 0.240 |
Why?
|
| Rabbits | 15 | 2011 | 231 | 0.240 |
Why?
|
| Paresis | 1 | 2006 | 18 | 0.240 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2007 | 53 | 0.240 |
Why?
|
| Finger Phalanges | 1 | 2006 | 7 | 0.240 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2013 | 755 | 0.240 |
Why?
|
| Gene Expression Regulation | 2 | 2007 | 526 | 0.240 |
Why?
|
| Equipment Design | 4 | 2013 | 192 | 0.230 |
Why?
|
| Vascular Diseases | 5 | 2005 | 69 | 0.230 |
Why?
|
| Osteogenesis, Distraction | 2 | 2006 | 20 | 0.230 |
Why?
|
| Disability Evaluation | 5 | 2015 | 262 | 0.230 |
Why?
|
| Tendons | 4 | 2013 | 61 | 0.220 |
Why?
|
| Forearm Injuries | 3 | 1999 | 10 | 0.220 |
Why?
|
| Analgesia | 1 | 2005 | 32 | 0.220 |
Why?
|
| Skin | 6 | 1998 | 224 | 0.220 |
Why?
|
| Medicaid | 2 | 2002 | 105 | 0.220 |
Why?
|
| Vasoconstriction | 6 | 2000 | 46 | 0.210 |
Why?
|
| Pseudarthrosis | 2 | 1997 | 8 | 0.210 |
Why?
|
| Arthroscopy | 7 | 2011 | 254 | 0.210 |
Why?
|
| Health Care Sector | 3 | 2008 | 18 | 0.200 |
Why?
|
| Industry | 3 | 2008 | 16 | 0.200 |
Why?
|
| Infant | 9 | 2004 | 1123 | 0.200 |
Why?
|
| Ulnar Nerve | 1 | 2003 | 24 | 0.190 |
Why?
|
| RNA, Messenger | 3 | 2013 | 545 | 0.190 |
Why?
|
| Depressive Disorder, Major | 1 | 2003 | 41 | 0.190 |
Why?
|
| North Carolina | 4 | 2022 | 1613 | 0.190 |
Why?
|
| Motor Neurons | 1 | 2002 | 66 | 0.180 |
Why?
|
| Wrist Joint | 4 | 2015 | 64 | 0.180 |
Why?
|
| Mothers | 1 | 2003 | 94 | 0.180 |
Why?
|
| Scleroderma, Localized | 1 | 2002 | 6 | 0.180 |
Why?
|
| Wound Healing | 3 | 2011 | 190 | 0.180 |
Why?
|
| Antitrust Laws | 1 | 2022 | 3 | 0.180 |
Why?
|
| Adaptation, Psychological | 1 | 2003 | 145 | 0.180 |
Why?
|
| Neuronal Plasticity | 1 | 2002 | 86 | 0.180 |
Why?
|
| Tendon Injuries | 2 | 2013 | 40 | 0.180 |
Why?
|
| Hemiplegia | 4 | 2011 | 12 | 0.180 |
Why?
|
| Radiography | 9 | 2014 | 397 | 0.180 |
Why?
|
| Skin Temperature | 6 | 2011 | 17 | 0.180 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2019 | 33 | 0.180 |
Why?
|
| Venous Thrombosis | 1 | 2002 | 49 | 0.170 |
Why?
|
| Ligaments | 2 | 1992 | 16 | 0.170 |
Why?
|
| Health Services Needs and Demand | 1 | 2002 | 84 | 0.170 |
Why?
|
| Stress, Psychological | 1 | 2003 | 233 | 0.170 |
Why?
|
| Ligaments, Articular | 2 | 1999 | 53 | 0.170 |
Why?
|
| Amputation | 5 | 2015 | 44 | 0.170 |
Why?
|
| Hair | 2 | 2013 | 31 | 0.170 |
Why?
|
| Education, Medical, Graduate | 1 | 2022 | 138 | 0.170 |
Why?
|
| Rotator Cuff | 2 | 2011 | 77 | 0.170 |
Why?
|
| Caregivers | 1 | 2002 | 116 | 0.160 |
Why?
|
| Vascular Patency | 5 | 2008 | 71 | 0.160 |
Why?
|
| Hand Strength | 2 | 2021 | 106 | 0.160 |
Why?
|
| Drug Administration Schedule | 3 | 2013 | 306 | 0.160 |
Why?
|
| Ear, External | 4 | 1998 | 7 | 0.160 |
Why?
|
| Muscles | 4 | 2013 | 69 | 0.160 |
Why?
|
| MEDLARS | 1 | 2000 | 1 | 0.160 |
Why?
|
| Serial Publications | 1 | 2000 | 3 | 0.160 |
Why?
|
| MEDLINE | 1 | 2000 | 5 | 0.160 |
Why?
|
| Patient Selection | 2 | 2019 | 291 | 0.150 |
Why?
|
| Compartment Syndromes | 1 | 2000 | 38 | 0.150 |
Why?
|
| Aged, 80 and over | 9 | 2021 | 4157 | 0.150 |
Why?
|
| Microsurgery | 3 | 1997 | 22 | 0.150 |
Why?
|
| Muscle Denervation | 2 | 2011 | 31 | 0.150 |
Why?
|
| Analysis of Variance | 5 | 2008 | 508 | 0.150 |
Why?
|
| Severity of Illness Index | 3 | 2018 | 922 | 0.150 |
Why?
|
| Scaphoid Bone | 1 | 1999 | 10 | 0.150 |
Why?
|
| Double-Blind Method | 3 | 2013 | 597 | 0.150 |
Why?
|
| Arm Injuries | 2 | 1998 | 22 | 0.150 |
Why?
|
| Radius | 1 | 1999 | 27 | 0.140 |
Why?
|
| Fracture Fixation, Intramedullary | 3 | 2015 | 42 | 0.140 |
Why?
|
| Sensation Disorders | 1 | 1998 | 12 | 0.140 |
Why?
|
| Athletic Injuries | 3 | 2005 | 97 | 0.140 |
Why?
|
| Infant, Newborn | 6 | 2003 | 730 | 0.130 |
Why?
|
| Gait | 4 | 2001 | 134 | 0.130 |
Why?
|
| Debridement | 3 | 2011 | 47 | 0.130 |
Why?
|
| Animals, Newborn | 3 | 2010 | 143 | 0.130 |
Why?
|
| Recurrence | 4 | 2012 | 296 | 0.130 |
Why?
|
| Angiography | 4 | 2008 | 79 | 0.130 |
Why?
|
| Disease Models, Animal | 7 | 2011 | 1129 | 0.130 |
Why?
|
| Splints | 2 | 2010 | 15 | 0.130 |
Why?
|
| Ganglia | 1 | 1997 | 1 | 0.130 |
Why?
|
| Synovial Cyst | 1 | 1997 | 1 | 0.130 |
Why?
|
| Tenosynovitis | 1 | 1997 | 2 | 0.130 |
Why?
|
| Carpal Bones | 1 | 1997 | 16 | 0.130 |
Why?
|
| Anastomosis, Surgical | 4 | 2008 | 60 | 0.120 |
Why?
|
| Arthritis, Infectious | 1 | 1997 | 27 | 0.120 |
Why?
|
| Electrophysiological Phenomena | 2 | 2013 | 31 | 0.120 |
Why?
|
| Osteomyelitis | 1 | 1997 | 31 | 0.120 |
Why?
|
| Glomus Tumor | 1 | 2016 | 5 | 0.120 |
Why?
|
| Reference Values | 3 | 2013 | 265 | 0.120 |
Why?
|
| Bacteremia | 1 | 1997 | 69 | 0.120 |
Why?
|
| Aging | 1 | 2002 | 1010 | 0.120 |
Why?
|
| Research Support as Topic | 2 | 2013 | 36 | 0.120 |
Why?
|
| Incidence | 3 | 2016 | 1290 | 0.120 |
Why?
|
| Staphylococcal Infections | 1 | 1997 | 83 | 0.120 |
Why?
|
| Axilla | 1 | 2015 | 18 | 0.120 |
Why?
|
| Connective Tissue Diseases | 1 | 1995 | 7 | 0.120 |
Why?
|
| Gene Expression Profiling | 2 | 2007 | 341 | 0.110 |
Why?
|
| Ulnar Neuropathies | 1 | 2015 | 17 | 0.110 |
Why?
|
| Stress, Physiological | 2 | 1994 | 60 | 0.110 |
Why?
|
| Activities of Daily Living | 2 | 2021 | 267 | 0.110 |
Why?
|
| Evidence-Based Medicine | 2 | 2010 | 230 | 0.110 |
Why?
|
| Ketamine | 2 | 2011 | 20 | 0.110 |
Why?
|
| Foot | 3 | 2008 | 43 | 0.110 |
Why?
|
| Patient Participation | 1 | 2016 | 93 | 0.110 |
Why?
|
| Bone Nails | 1 | 2015 | 42 | 0.110 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 3 | 2000 | 19 | 0.110 |
Why?
|
| Joint Instability | 2 | 2015 | 91 | 0.110 |
Why?
|
| Mice, Inbred Strains | 2 | 2011 | 57 | 0.110 |
Why?
|
| Mice | 5 | 2011 | 2720 | 0.110 |
Why?
|
| Autonomic Nerve Block | 2 | 2011 | 11 | 0.100 |
Why?
|
| Transplantation, Homologous | 2 | 2023 | 165 | 0.100 |
Why?
|
| Hot Temperature | 3 | 2010 | 89 | 0.100 |
Why?
|
| Movement Disorders | 2 | 2004 | 29 | 0.100 |
Why?
|
| Physical Therapy Modalities | 2 | 2011 | 84 | 0.100 |
Why?
|
| Thrombolytic Therapy | 1 | 2014 | 67 | 0.100 |
Why?
|
| Algorithms | 2 | 2015 | 561 | 0.100 |
Why?
|
| Interprofessional Relations | 3 | 2008 | 48 | 0.100 |
Why?
|
| Foot Diseases | 1 | 1993 | 12 | 0.100 |
Why?
|
| Prevalence | 2 | 2011 | 1034 | 0.100 |
Why?
|
| Lunate Bone | 2 | 2011 | 14 | 0.100 |
Why?
|
| Muscle Relaxation | 1 | 2013 | 21 | 0.100 |
Why?
|
| Hyperhidrosis | 1 | 2012 | 6 | 0.100 |
Why?
|
| Models, Animal | 3 | 2008 | 198 | 0.100 |
Why?
|
| Calcaneus | 1 | 1993 | 14 | 0.100 |
Why?
|
| Sciatic Nerve | 2 | 2007 | 39 | 0.100 |
Why?
|
| Nail Diseases | 1 | 2013 | 6 | 0.100 |
Why?
|
| Cryotherapy | 1 | 1993 | 13 | 0.100 |
Why?
|
| Thumb | 3 | 1990 | 7 | 0.100 |
Why?
|
| Medical History Taking | 2 | 2010 | 41 | 0.100 |
Why?
|
| Bioreactors | 1 | 2013 | 61 | 0.090 |
Why?
|
| Contusions | 1 | 1993 | 41 | 0.090 |
Why?
|
| Functional Laterality | 2 | 2011 | 66 | 0.090 |
Why?
|
| Humeral Fractures | 3 | 2002 | 38 | 0.090 |
Why?
|
| Renal Dialysis | 1 | 2015 | 282 | 0.090 |
Why?
|
| Synovitis | 2 | 2011 | 8 | 0.090 |
Why?
|
| Forearm | 5 | 1999 | 49 | 0.090 |
Why?
|
| Physical Examination | 2 | 2010 | 94 | 0.090 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2011 | 6 | 0.090 |
Why?
|
| Efferent Pathways | 1 | 2011 | 11 | 0.090 |
Why?
|
| Motor Cortex | 1 | 2011 | 13 | 0.090 |
Why?
|
| Observer Variation | 2 | 2009 | 110 | 0.090 |
Why?
|
| Osteochondritis | 1 | 2011 | 6 | 0.090 |
Why?
|
| Macaca fascicularis | 1 | 2013 | 549 | 0.090 |
Why?
|
| Sweating | 1 | 2011 | 16 | 0.090 |
Why?
|
| Models, Biological | 2 | 2011 | 432 | 0.090 |
Why?
|
| Truth Disclosure | 1 | 2011 | 15 | 0.090 |
Why?
|
| Electric Stimulation Therapy | 1 | 2011 | 19 | 0.090 |
Why?
|
| Arthralgia | 1 | 2011 | 33 | 0.090 |
Why?
|
| Sympathetic Nervous System | 1 | 2011 | 34 | 0.090 |
Why?
|
| Ethics, Clinical | 2 | 2008 | 9 | 0.090 |
Why?
|
| Anticonvulsants | 1 | 2011 | 62 | 0.090 |
Why?
|
| Melanoma | 1 | 2013 | 170 | 0.090 |
Why?
|
| Femur Head Necrosis | 3 | 2001 | 11 | 0.090 |
Why?
|
| Trisomy | 1 | 1991 | 12 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 1991 | 21 | 0.080 |
Why?
|
| Antidepressive Agents | 1 | 2011 | 78 | 0.080 |
Why?
|
| Professional Competence | 2 | 2008 | 18 | 0.080 |
Why?
|
| Afghan Campaign 2001- | 1 | 2011 | 14 | 0.080 |
Why?
|
| Research Design | 1 | 2013 | 337 | 0.080 |
Why?
|
| Delivery of Health Care | 2 | 2010 | 176 | 0.080 |
Why?
|
| Electrophysiology | 3 | 2007 | 77 | 0.080 |
Why?
|
| Publishing | 1 | 2011 | 66 | 0.080 |
Why?
|
| Abnormalities, Multiple | 1 | 1991 | 28 | 0.080 |
Why?
|
| Phenol | 2 | 2008 | 11 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2011 | 988 | 0.080 |
Why?
|
| Brain Mapping | 1 | 2011 | 208 | 0.080 |
Why?
|
| Phonophoresis | 1 | 2010 | 2 | 0.080 |
Why?
|
| X-Ray Microtomography | 1 | 2010 | 45 | 0.080 |
Why?
|
| Iontophoresis | 1 | 2010 | 7 | 0.080 |
Why?
|
| Multiple Trauma | 1 | 2011 | 42 | 0.080 |
Why?
|
| Analgesics | 1 | 2011 | 117 | 0.080 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2010 | 11 | 0.080 |
Why?
|
| Epiphyses, Slipped | 1 | 1990 | 4 | 0.080 |
Why?
|
| Reaction Time | 1 | 2011 | 131 | 0.080 |
Why?
|
| Bandages | 1 | 2010 | 34 | 0.080 |
Why?
|
| Hand Deformities, Congenital | 1 | 1990 | 8 | 0.080 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2011 | 123 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2015 | 548 | 0.080 |
Why?
|
| Femur Head | 1 | 1990 | 12 | 0.080 |
Why?
|
| Periodicals as Topic | 1 | 2011 | 91 | 0.080 |
Why?
|
| Economic Recession | 1 | 2010 | 1 | 0.080 |
Why?
|
| History, 20th Century | 2 | 2002 | 76 | 0.080 |
Why?
|
| Relative Value Scales | 1 | 2010 | 2 | 0.080 |
Why?
|
| Skin Neoplasms | 1 | 2013 | 225 | 0.080 |
Why?
|
| Biomedical Technology | 1 | 2010 | 5 | 0.080 |
Why?
|
| Cicatrix | 1 | 2010 | 41 | 0.080 |
Why?
|
| Health Care Rationing | 1 | 2010 | 12 | 0.080 |
Why?
|
| Synaptic Transmission | 1 | 2011 | 125 | 0.080 |
Why?
|
| United States Government Agencies | 1 | 2019 | 1 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 281 | 0.080 |
Why?
|
| Arteriovenous Anastomosis | 3 | 2000 | 4 | 0.080 |
Why?
|
| Sample Size | 1 | 2019 | 40 | 0.080 |
Why?
|
| Health Facilities | 1 | 2019 | 15 | 0.080 |
Why?
|
| Research Personnel | 1 | 2019 | 24 | 0.080 |
Why?
|
| Congresses as Topic | 1 | 2019 | 44 | 0.080 |
Why?
|
| Health Care Reform | 1 | 2010 | 45 | 0.080 |
Why?
|
| Government Regulation | 1 | 2019 | 32 | 0.080 |
Why?
|
| Clinical Competence | 2 | 2019 | 349 | 0.080 |
Why?
|
| Acute Disease | 2 | 2014 | 277 | 0.080 |
Why?
|
| Ankle | 2 | 2011 | 32 | 0.070 |
Why?
|
| Injury Severity Score | 1 | 2019 | 113 | 0.070 |
Why?
|
| Rupture | 2 | 2007 | 36 | 0.070 |
Why?
|
| Postoperative Care | 1 | 2019 | 80 | 0.070 |
Why?
|
| Age Factors | 2 | 2019 | 1262 | 0.070 |
Why?
|
| Health Status | 2 | 2004 | 411 | 0.070 |
Why?
|
| Fasciitis, Plantar | 1 | 2008 | 3 | 0.070 |
Why?
|
| Exocytosis | 1 | 2008 | 11 | 0.070 |
Why?
|
| Injections, Intralesional | 1 | 2008 | 16 | 0.070 |
Why?
|
| Occupational Therapy | 1 | 2008 | 5 | 0.070 |
Why?
|
| Tennis Elbow | 1 | 2008 | 19 | 0.070 |
Why?
|
| Neurotransmitter Agents | 1 | 2008 | 35 | 0.070 |
Why?
|
| Necrosis | 1 | 2008 | 55 | 0.070 |
Why?
|
| Tibial Nerve | 1 | 2008 | 22 | 0.070 |
Why?
|
| Arthroplasty, Replacement | 1 | 2008 | 19 | 0.070 |
Why?
|
| Quadriplegia | 1 | 2008 | 12 | 0.070 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2008 | 14 | 0.070 |
Why?
|
| Accidents, Traffic | 1 | 2011 | 210 | 0.070 |
Why?
|
| Professional Role | 1 | 2008 | 21 | 0.070 |
Why?
|
| Paralysis | 1 | 2007 | 14 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2019 | 585 | 0.070 |
Why?
|
| Decision Making | 1 | 2010 | 203 | 0.070 |
Why?
|
| Toes | 3 | 1996 | 18 | 0.070 |
Why?
|
| Gangrene | 1 | 2007 | 5 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2019 | 1508 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2008 | 103 | 0.070 |
Why?
|
| Suture Techniques | 1 | 2007 | 61 | 0.060 |
Why?
|
| Immobilization | 2 | 2006 | 9 | 0.060 |
Why?
|
| Tissue Engineering | 1 | 2013 | 700 | 0.060 |
Why?
|
| Reflex | 1 | 2007 | 21 | 0.060 |
Why?
|
| Prazosin | 4 | 2012 | 12 | 0.060 |
Why?
|
| Radionuclide Angiography | 2 | 1983 | 2 | 0.060 |
Why?
|
| Radial Nerve | 2 | 2015 | 18 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2006 | 12 | 0.060 |
Why?
|
| Myogenin | 1 | 2006 | 5 | 0.060 |
Why?
|
| Foot Injuries | 1 | 1986 | 14 | 0.060 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2008 | 108 | 0.060 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2006 | 18 | 0.060 |
Why?
|
| Atrophy | 1 | 2006 | 51 | 0.060 |
Why?
|
| Receptors, Cholinergic | 1 | 2006 | 26 | 0.060 |
Why?
|
| Hip | 2 | 2002 | 17 | 0.060 |
Why?
|
| Collateral Ligaments | 1 | 2006 | 10 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 823 | 0.060 |
Why?
|
| Ankle Injuries | 1 | 1986 | 25 | 0.060 |
Why?
|
| Elbow Joint | 1 | 2007 | 68 | 0.060 |
Why?
|
| Biocompatible Materials | 1 | 2007 | 242 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2006 | 87 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 175 | 0.060 |
Why?
|
| Models, Cardiovascular | 3 | 1998 | 33 | 0.060 |
Why?
|
| MyoD Protein | 1 | 2005 | 10 | 0.060 |
Why?
|
| Reoperation | 2 | 1997 | 265 | 0.060 |
Why?
|
| Vasomotor System | 3 | 1993 | 25 | 0.060 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2005 | 16 | 0.060 |
Why?
|
| Hallux | 1 | 1985 | 10 | 0.060 |
Why?
|
| Prognosis | 3 | 2019 | 1606 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2008 | 430 | 0.050 |
Why?
|
| Foot Deformities | 1 | 2004 | 2 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 130 | 0.050 |
Why?
|
| Chronic Disease | 3 | 2011 | 439 | 0.050 |
Why?
|
| Neuromuscular Blocking Agents | 2 | 1996 | 7 | 0.050 |
Why?
|
| Gene Expression | 1 | 2005 | 363 | 0.050 |
Why?
|
| Random Allocation | 3 | 2011 | 257 | 0.050 |
Why?
|
| Parasympatholytics | 1 | 2003 | 6 | 0.050 |
Why?
|
| Smoking | 3 | 2015 | 544 | 0.050 |
Why?
|
| Autonomic Nervous System | 1 | 2004 | 51 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 1997 | 590 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2005 | 268 | 0.050 |
Why?
|
| Fractures, Spontaneous | 2 | 1997 | 16 | 0.050 |
Why?
|
| Electrodiagnosis | 2 | 2015 | 42 | 0.050 |
Why?
|
| Family Health | 1 | 2003 | 79 | 0.050 |
Why?
|
| Cell Count | 1 | 2002 | 55 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2003 | 310 | 0.050 |
Why?
|
| Leg Length Inequality | 1 | 1982 | 1 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 703 | 0.050 |
Why?
|
| Tensile Strength | 2 | 2013 | 60 | 0.050 |
Why?
|
| Fee-for-Service Plans | 1 | 2002 | 14 | 0.050 |
Why?
|
| History, 19th Century | 1 | 2002 | 15 | 0.050 |
Why?
|
| Psoas Muscles | 1 | 2002 | 21 | 0.040 |
Why?
|
| Stress, Mechanical | 2 | 2011 | 102 | 0.040 |
Why?
|
| Social Support | 1 | 2003 | 195 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2002 | 63 | 0.040 |
Why?
|
| Brachial Artery | 1 | 2002 | 76 | 0.040 |
Why?
|
| Diagnosis, Differential | 3 | 2013 | 542 | 0.040 |
Why?
|
| Singapore | 1 | 2021 | 12 | 0.040 |
Why?
|
| Femur | 1 | 1982 | 82 | 0.040 |
Why?
|
| Axons | 2 | 2013 | 36 | 0.040 |
Why?
|
| Health Surveys | 1 | 2002 | 202 | 0.040 |
Why?
|
| Canada | 1 | 2021 | 69 | 0.040 |
Why?
|
| Pulmonary Embolism | 1 | 2002 | 52 | 0.040 |
Why?
|
| Neural Conduction | 2 | 2013 | 92 | 0.040 |
Why?
|
| Femoral Vein | 2 | 1997 | 8 | 0.040 |
Why?
|
| Phenylephrine | 3 | 2000 | 35 | 0.040 |
Why?
|
| Action Potentials | 2 | 2013 | 220 | 0.040 |
Why?
|
| Testicular Hydrocele | 1 | 1990 | 2 | 0.040 |
Why?
|
| Sclerotherapy | 1 | 1990 | 8 | 0.040 |
Why?
|
| Saphenous Vein | 1 | 2000 | 22 | 0.040 |
Why?
|
| Multimedia | 1 | 2000 | 19 | 0.040 |
Why?
|
| Hip Joint | 2 | 2000 | 70 | 0.040 |
Why?
|
| Guided Tissue Regeneration | 2 | 2011 | 39 | 0.040 |
Why?
|
| Decompression, Surgical | 1 | 2010 | 57 | 0.040 |
Why?
|
| Membranes | 1 | 1999 | 12 | 0.040 |
Why?
|
| Cartilage | 1 | 1999 | 33 | 0.040 |
Why?
|
| Receptors, Adrenergic | 1 | 1998 | 13 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1998 | 12 | 0.030 |
Why?
|
| Injections | 2 | 2011 | 76 | 0.030 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 1998 | 35 | 0.030 |
Why?
|
| Bone Neoplasms | 2 | 1997 | 122 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 1998 | 124 | 0.030 |
Why?
|
| Osteosarcoma | 1 | 1997 | 11 | 0.030 |
Why?
|
| Fibula | 1 | 1997 | 14 | 0.030 |
Why?
|
| Comorbidity | 1 | 2019 | 596 | 0.030 |
Why?
|
| Skin Transplantation | 1 | 1997 | 50 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2002 | 1607 | 0.030 |
Why?
|
| Tibia | 1 | 1997 | 62 | 0.030 |
Why?
|
| Wounds, Gunshot | 1 | 1997 | 35 | 0.030 |
Why?
|
| Hydrogels | 2 | 2008 | 127 | 0.030 |
Why?
|
| Oxacillin | 1 | 1997 | 6 | 0.030 |
Why?
|
| Duodenum | 1 | 1997 | 20 | 0.030 |
Why?
|
| Penicillins | 1 | 1997 | 12 | 0.030 |
Why?
|
| Perfusion | 2 | 1996 | 78 | 0.030 |
Why?
|
| Venules | 2 | 1998 | 5 | 0.030 |
Why?
|
| Intestinal Obstruction | 1 | 1997 | 12 | 0.030 |
Why?
|
| Arterioles | 2 | 1998 | 17 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 1997 | 100 | 0.030 |
Why?
|
| Clonidine | 2 | 2000 | 66 | 0.030 |
Why?
|
| Fracture Healing | 1 | 1997 | 44 | 0.030 |
Why?
|
| Extremities | 1 | 2016 | 55 | 0.030 |
Why?
|
| Blood Vessels | 2 | 1987 | 60 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 138 | 0.030 |
Why?
|
| Blood Flow Velocity | 2 | 1993 | 87 | 0.030 |
Why?
|
| Nicotine | 1 | 1998 | 179 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2002 | 803 | 0.030 |
Why?
|
| Smoking Cessation | 1 | 1998 | 216 | 0.030 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2016 | 48 | 0.030 |
Why?
|
| Sex Factors | 1 | 1998 | 708 | 0.030 |
Why?
|
| Nerve Transfer | 1 | 2015 | 19 | 0.030 |
Why?
|
| Young Adult | 2 | 2015 | 2831 | 0.030 |
Why?
|
| Fractures, Closed | 1 | 2015 | 10 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 1985 | 96 | 0.030 |
Why?
|
| Blood Pressure | 2 | 1992 | 901 | 0.030 |
Why?
|
| Drug Utilization | 1 | 2015 | 53 | 0.030 |
Why?
|
| Leg Injuries | 2 | 1987 | 12 | 0.030 |
Why?
|
| Diabetic Angiopathies | 1 | 2015 | 153 | 0.030 |
Why?
|
| Cohort Studies | 1 | 1998 | 1910 | 0.030 |
Why?
|
| Tolonium Chloride | 1 | 2013 | 2 | 0.030 |
Why?
|
| Myelin Sheath | 1 | 2013 | 12 | 0.030 |
Why?
|
| Antibodies | 1 | 2013 | 59 | 0.030 |
Why?
|
| Locomotion | 1 | 1993 | 37 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 354 | 0.020 |
Why?
|
| Norepinephrine | 3 | 1998 | 103 | 0.020 |
Why?
|
| Xylazine | 1 | 1993 | 1 | 0.020 |
Why?
|
| Nails | 1 | 2013 | 6 | 0.020 |
Why?
|
| Injections, Intradermal | 1 | 2012 | 8 | 0.020 |
Why?
|
| Hemodynamics | 1 | 1994 | 168 | 0.020 |
Why?
|
| Retreatment | 1 | 2012 | 43 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 136 | 0.020 |
Why?
|
| Anesthesia, Conduction | 1 | 2012 | 27 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2015 | 265 | 0.020 |
Why?
|
| Methods | 3 | 1996 | 13 | 0.020 |
Why?
|
| Anesthesia | 1 | 1993 | 72 | 0.020 |
Why?
|
| Yohimbine | 1 | 2012 | 7 | 0.020 |
Why?
|
| Tetrodotoxin | 1 | 2012 | 14 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 1992 | 25 | 0.020 |
Why?
|
| Evoked Potentials, Motor | 1 | 2011 | 8 | 0.020 |
Why?
|
| Aorta, Abdominal | 1 | 1992 | 33 | 0.020 |
Why?
|
| Rheology | 1 | 1992 | 35 | 0.020 |
Why?
|
| Albuterol | 1 | 1992 | 19 | 0.020 |
Why?
|
| Biopsy | 1 | 2013 | 273 | 0.020 |
Why?
|
| Authorship | 1 | 2011 | 9 | 0.020 |
Why?
|
| Catheterization, Peripheral | 1 | 1992 | 29 | 0.020 |
Why?
|
| Vasodilation | 1 | 2012 | 96 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 939 | 0.020 |
Why?
|
| Elastic Modulus | 1 | 2011 | 29 | 0.020 |
Why?
|
| Motor Activity | 1 | 2013 | 356 | 0.020 |
Why?
|
| Cattle | 1 | 2011 | 118 | 0.020 |
Why?
|
| Probability | 1 | 2011 | 168 | 0.020 |
Why?
|
| Radionuclide Imaging | 2 | 1993 | 30 | 0.020 |
Why?
|
| Organ Size | 1 | 2011 | 236 | 0.020 |
Why?
|
| Accidental Falls | 1 | 2011 | 116 | 0.020 |
Why?
|
| Metacarpophalangeal Joint | 1 | 1990 | 4 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2011 | 129 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2011 | 256 | 0.020 |
Why?
|
| Bone Screws | 1 | 1990 | 64 | 0.020 |
Why?
|
| Arthrodesis | 1 | 1990 | 30 | 0.020 |
Why?
|
| Collagen | 1 | 2011 | 240 | 0.020 |
Why?
|
| Sensation | 1 | 1990 | 60 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 614 | 0.020 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2008 | 35 | 0.020 |
Why?
|
| Anti-Dyskinesia Agents | 1 | 2008 | 6 | 0.020 |
Why?
|
| Sural Nerve | 1 | 2008 | 28 | 0.020 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2008 | 19 | 0.020 |
Why?
|
| Ethics, Professional | 1 | 2008 | 9 | 0.020 |
Why?
|
| Adrenergic alpha-Antagonists | 2 | 1998 | 36 | 0.020 |
Why?
|
| Freezing | 1 | 2007 | 7 | 0.020 |
Why?
|
| Adrenergic alpha-Agonists | 2 | 1998 | 46 | 0.020 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2007 | 14 | 0.020 |
Why?
|
| Hip Dislocation, Congenital | 1 | 1987 | 8 | 0.020 |
Why?
|
| Professional-Patient Relations | 1 | 2008 | 24 | 0.020 |
Why?
|
| Porosity | 1 | 2007 | 41 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 1988 | 69 | 0.020 |
Why?
|
| Myositis Ossificans | 1 | 1987 | 3 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2008 | 168 | 0.020 |
Why?
|
| Sarcomeres | 1 | 2006 | 5 | 0.020 |
Why?
|
| Cell Line | 1 | 2007 | 476 | 0.020 |
Why?
|
| Fascia Lata | 1 | 1986 | 3 | 0.020 |
Why?
|
| Bone Lengthening | 1 | 1986 | 7 | 0.020 |
Why?
|
| Ankle Joint | 1 | 2006 | 51 | 0.010 |
Why?
|
| Risk Factors | 1 | 2014 | 4137 | 0.010 |
Why?
|
| Bone Diseases | 1 | 1985 | 19 | 0.010 |
Why?
|
| Myogenic Regulatory Factor 5 | 1 | 2005 | 7 | 0.010 |
Why?
|
| Nifedipine | 1 | 1985 | 10 | 0.010 |
Why?
|
| Surgery, Plastic | 2 | 1982 | 29 | 0.010 |
Why?
|
| Ulna | 1 | 1985 | 20 | 0.010 |
Why?
|
| Consumer Satisfaction | 1 | 1985 | 1 | 0.010 |
Why?
|
| Tissue Survival | 1 | 1985 | 13 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2005 | 45 | 0.010 |
Why?
|
| Synaptosomal-Associated Protein 25 | 1 | 2005 | 8 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 2005 | 69 | 0.010 |
Why?
|
| Graft Occlusion, Vascular | 1 | 1985 | 25 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2005 | 41 | 0.010 |
Why?
|
| Movement | 1 | 1985 | 63 | 0.010 |
Why?
|
| Body Weights and Measures | 1 | 2004 | 26 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 154 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2001 | 1393 | 0.010 |
Why?
|
| Dystonic Disorders | 1 | 2004 | 14 | 0.010 |
Why?
|
| Baseball | 1 | 2005 | 48 | 0.010 |
Why?
|
| Diazepam | 1 | 2003 | 6 | 0.010 |
Why?
|
| Muscle Relaxants, Central | 1 | 2003 | 12 | 0.010 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1984 | 54 | 0.010 |
Why?
|
| Baclofen | 1 | 2003 | 28 | 0.010 |
Why?
|
| Injections, Spinal | 1 | 2003 | 124 | 0.010 |
Why?
|
| Thermography | 1 | 1983 | 3 | 0.010 |
Why?
|
| Plethysmography | 1 | 1983 | 18 | 0.010 |
Why?
|
| Physical Exertion | 1 | 1983 | 15 | 0.010 |
Why?
|
| Bone Wires | 1 | 2002 | 12 | 0.010 |
Why?
|
| Pulse | 1 | 2002 | 11 | 0.010 |
Why?
|
| Drug Utilization Review | 1 | 2002 | 20 | 0.010 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2002 | 45 | 0.010 |
Why?
|
| Anthropometry | 1 | 1982 | 89 | 0.010 |
Why?
|
| Drug Costs | 1 | 2002 | 51 | 0.010 |
Why?
|
| Ethanol | 1 | 2003 | 199 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2002 | 197 | 0.010 |
Why?
|
| Sodium Tetradecyl Sulfate | 1 | 1990 | 1 | 0.010 |
Why?
|
| Sclerosing Solutions | 1 | 1990 | 4 | 0.010 |
Why?
|
| Ultrasonography, Interventional | 1 | 2000 | 57 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 1990 | 214 | 0.010 |
Why?
|
| Piperazines | 1 | 2000 | 64 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1998 | 19 | 0.010 |
Why?
|
| Carbon Monoxide | 1 | 1998 | 10 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2000 | 242 | 0.010 |
Why?
|
| Graft Survival | 1 | 2000 | 315 | 0.010 |
Why?
|
| Dogs | 1 | 1998 | 130 | 0.010 |
Why?
|
| Medetomidine | 1 | 1998 | 2 | 0.010 |
Why?
|
| Propranolol | 1 | 1998 | 18 | 0.010 |
Why?
|
| Administration, Cutaneous | 1 | 1998 | 119 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1998 | 67 | 0.010 |
Why?
|
| Imidazoles | 1 | 1998 | 99 | 0.010 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 1996 | 4 | 0.010 |
Why?
|
| Patient Compliance | 1 | 1998 | 218 | 0.010 |
Why?
|
| Vasoconstrictor Agents | 1 | 1996 | 65 | 0.010 |
Why?
|
| Vena Cava, Inferior | 1 | 1996 | 30 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1996 | 104 | 0.010 |
Why?
|
| Bioprosthesis | 1 | 1996 | 62 | 0.010 |
Why?
|
| Capillaries | 1 | 1994 | 30 | 0.010 |
Why?
|
| Technetium | 1 | 1993 | 7 | 0.010 |
Why?
|
| Reperfusion Injury | 1 | 1994 | 60 | 0.010 |
Why?
|
| Bone and Bones | 1 | 1993 | 99 | 0.010 |
Why?
|
| Shoulder Fractures | 1 | 1988 | 6 | 0.000 |
Why?
|
| Football | 1 | 1987 | 82 | 0.000 |
Why?
|
| Chondroma | 1 | 1985 | 4 | 0.000 |
Why?
|
| Osteochondritis Dissecans | 1 | 1985 | 16 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1985 | 213 | 0.000 |
Why?
|
| Scapula | 1 | 1982 | 20 | 0.000 |
Why?
|
| Shoulder | 1 | 1982 | 51 | 0.000 |
Why?
|
| Blood Vessel Prosthesis | 1 | 1982 | 87 | 0.000 |
Why?
|